← Evidence library

BIB_058

Weber J, Mandala M, Del Vecchio M, et al. Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma. NEJM 2017;377:1824–1835. CheckMate-238. [Tasks: L, 18] Tier: 2 Grade: A Retrieved: 2026-05-06

Evidence grade

A

Tier

2

Cited by tasks

L, 18

Identifiers

—

Full extracted findings & patient-implication analysis: bibliography/BIB_058/findings.md (research corpus). This page is a short context summary — not individualised medical advice.